NCT06583733

Brief Summary

KOKU Bladder aims to develop and test an evidence based digital health program with behavior change techniques to improve bladder health of adults aged 50 and over. A novel module embedded in the approved app "Keep-on-Keep-up" (KOKU) will be co-created with end-users, researchers, health professionals, and stakeholders through a participatory and appreciative action and reflection methodology. After a comprehensive literature review and consultation with 4-6 experts, 6 focus groups will be undertaken in Kaunas(Lithuanian), Catalonia (Spain) and Manchester (UK) to co-create the contents of the module. Data will be analyzed using thematic analysis. Gamification and the Honeycomb model for user experience will be followed to achieve an appropriate technological solution that will be tested through a randomized controlled trial with at least 120 individuals. A mixed methods approach (quantitative/qualitative analysis) will be used to assess the feasibility and acceptability of the program. Open data and science, gender and ethical aspects, as well as a risk management plan are considered. A plan for communication, dissemination, exploitation of results will be considered. KOKU Bladder will be highly scalable and will have wide reach and impact. This proposal is in line with EU policy initiatives on Active and Healthy Ageing (bladder health and continence will be promoted), targeting aspects such as eHealth, Innovation and Digital Care Transformation, by supporting users to demand more responsive and integrated care programs for chronic conditions and enhancing self-management strategies, independence and health intelligence.

Trial Health

80
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
29mo left

Started Mar 2025

Longer than P75 for not_applicable

Geographic Reach
3 countries

4 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress32%
Mar 2025Oct 2028

First Submitted

Initial submission to the registry

September 1, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 4, 2024

Completed
7 months until next milestone

Study Start

First participant enrolled

March 24, 2025

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2027

Expected
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2028

Last Updated

March 30, 2025

Status Verified

March 1, 2025

Enrollment Period

2.4 years

First QC Date

September 1, 2024

Last Update Submit

March 27, 2025

Conditions

Keywords

pelvic healthurinary incontinenceagedeHealthbehavior changephysical activitysedentary behaviorbladder healthtechnology

Outcome Measures

Primary Outcomes (1)

  • To co-create, develop and test an evidence based digital health program with behavior change techniques to decrease UI of community-dwelling adults aged 50 and over

    The primary aim of KOKU Bladder is to co-create and test an eHealth program to address bladder health (specifically urinary incontinence) in community-dwelling adults aged 50 and over

    3 years

Secondary Outcomes (5)

  • To evaluate the life-impact related to UI (Incontinence Impact Questionnaire-7) of community-dwelling adults aged 50 and over.

    3 years

  • To evaluate the lower urinary tract symptoms (International Prostate Symptom Score) of community-dwelling adults aged 50 and over.

    3 years

  • To evaluate the Patient Global Impression of Improvement; SB (visual analogue scale, a 7-day recall period) of community-dwelling adults aged 50 and over

    3 years

  • To evaluate the satisfaction with treatment of community-dwelling adults aged 50 and over.

    3 years

  • To modify the severity of UI (International Consultation on Incontinence Questionnaire-UI short form) of community-dwelling adults aged 50 and over

    3 years

Study Arms (2)

control group

ACTIVE COMPARATOR

The control group which will receive recommendations for self- managing urinary symptoms. There will be at least 60 participants (men and women mixed) distributed in 3 countries. It is anticipated that the multicomponent intervention will last 12 weeks. After the intervention we will collect the results with a mixed (qualitative and quantitative) approach.

Behavioral: recommendations

intervention group

EXPERIMENTAL

The intervention group, which will receive the treatment with KOKU Bladder. There will be at least 60 participants (men and women mixed) distributed in 3 countries. It is anticipated that the multicomponent intervention will last 12 weeks. After the intervention we will collect the results with a mixed (qualitative and quantitative) approach.

Behavioral: KOKU Bladder

Interventions

KOKU BladderBEHAVIORAL

In this intervention the participants will receive treatment with the KOKU app ( based digital health program with behavior change techniques to improve bladder health ) for 12 weeks. After the intervention we will collect the results with a mixed (qualitative and quantitative) approach. Qualitative information will be recorded and analysed through thematic analysis, and quantitative data will be collected with tests and questionnaires.

intervention group
recommendationsBEHAVIORAL

In this intervention the participants will receive recommendations for self- managing urinary symptoms, which they must follow for 12 weeks. After the intervention we will collect the results with a mixed (qualitative and quantitative) approach. Qualitative information will be recorded and analysed through thematic analysis, and quantitative data will be collected with tests and questionnaires.

control group

Eligibility Criteria

Age50 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥50 (range used in the literature covering the late-life process, including prostate issues and the perimenopause period)
  • Self-reported UI (at least 1 leakage/month)
  • Ability to read and understand the national languages
  • Have a mobile phone/tablet
  • Sign informed consent.

You may not qualify if:

  • Red-flag symptoms (e.g., bleeding)
  • Unstable health conditions.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Lithuanian Sports University

Kaunas, Lithuania

RECRUITING

Hospital Santa Maria

Lleida, Spain

RECRUITING

Hospital Consortium of Vic

Vic, Spain

RECRUITING

University of Manchester

Manchester, United Kingdom

NOT YET RECRUITING

Related Publications (1)

  • Jerez-Roig J, Aguila-Gimeno O, Brazaitis M, Solianik R, Karkauskiene E, Jarutiene L, Fuente-Vidal A, Borralleras-Fumana E, Gasteiger N, Stanmore E. Co-creating and testing a self-management digital solution for bladder health and urinary continence among people aged 50 and over: protocol for the international KOKU Bladder project. BMJ Open. 2025 Sep 11;15(9):e100487. doi: 10.1136/bmjopen-2025-100487.

MeSH Terms

Conditions

Urinary IncontinenceMotor ActivitySedentary Behavior

Interventions

Health Planning Guidelines

Condition Hierarchy (Ancestors)

Urination DisordersUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesLower Urinary Tract SymptomsUrological ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsBehavior

Intervention Hierarchy (Ancestors)

Health PlanningHealth Care Economics and Organizations

Study Officials

  • Jerez-Roig, PhD

    University of Vic-Central University of Catalonia; Lithuanian Sports University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Javier Jerez-Roig, Professor, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
Usually, in physiotherapist studies it is very difficult to do blinding, because the patients can do some physical activity or exercise. In this trial, participants blinding will not be possible because the patients know what treatment they do, they should do the different exercises with app or with a HB information. Also, it is necessary to do face-to-face assessment for the physiotherapist.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: 120 individuals will be simple randomised to a control (recommendations for self- managing urinary symptoms) or intervention (KOKU Bladder) group. It is anticipated that the multicomponent intervention will last 12 weeks and consist of health education, pelvic floor muscle exercises and BC techniques but this may vary according to the co-creation process. Measures will be assessed at baseline and end of intervention.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, Head of research group on Methodology, Methods, Models and Outcomes of Health and Social Science (M3O)

Study Record Dates

First Submitted

September 1, 2024

First Posted

September 4, 2024

Study Start

March 24, 2025

Primary Completion (Estimated)

August 31, 2027

Study Completion (Estimated)

October 1, 2028

Last Updated

March 30, 2025

Record last verified: 2025-03

Locations